Susquehanna Fundamental Investments, LLC Alkermes Plc. Transaction History

Susquehanna Fundamental Investments, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 07, 2024	BUY	$26.4 - $32.56 $2.28 Million - $2.81 Million	86,440 New	86,440 $2.34 Billion
Q3 2022 Nov 14, 2022	BUY	$22.0 - $31.87 $2.53 Million - $3.67 Million	115,036 Added 103.74%	225,930 $5.05 Million
Q1 2022 May 16, 2022	BUY	$23.07 - $27.99 $2.56 Million - $3.1 Million	110,894 New	110,894 $2.92 Million
Q3 2021 Nov 15, 2021	SELL	$23.37 - $32.13 $1.67 Million - $2.29 Million	-71,412 Closed	0 $0
Q2 2021 Aug 11, 2021	BUY	$18.78 - $25.15 $1.34 Million - $1.8 Million	71,412 New	71,412 $1.75 Million

361

181M

175K

96.6K

Ticker ALKS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 164,254,000
Market Cap $4.58B
Description
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.